Johnson & Johnson SG&A Expenses 2012-2026 | JNJ

Johnson & Johnson sg&a expenses for the twelve months ending March 31, 2026 were $24.598B, a 8.25% increase year-over-year.

  • Johnson & Johnson annual sg&a expenses for 2025 were $23.676B, a 3.53% increase from 2024.
  • Johnson & Johnson annual sg&a expenses for 2024 were $22.869B, a 6.31% increase from 2023.
  • Johnson & Johnson annual sg&a expenses for 2023 were $21.512B, a 6.25% increase from 2022.

Johnson & Johnson SG&A Expenses 2012-2026 | JNJ

  • Johnson & Johnson annual sg&a expenses for 2025 were $23.676B, a 3.53% increase from 2024.
  • Johnson & Johnson annual sg&a expenses for 2024 were $22.869B, a 6.31% increase from 2023.
  • Johnson & Johnson annual sg&a expenses for 2023 were $21.512B, a 6.25% increase from 2022.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$887.6B
AbbVie (ABBV)$367.7B
Roche Holding AG (RHHBY)$318.8B
Merck (MRK)$299.9B
Novartis AG (NVS)$294B
Novo Nordisk (NVO)$167.5B
Pfizer (PFE)$153.1B
Sanofi (SNY)$114B
Bayer (BAYRY)$46.2B
Innoviva (INVA)$1.8B